John M. Goldman | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where John M. Goldman is active.

Explore More

Publication

Featured researches published by John M. Goldman.

Blood | 2001

The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins

Asuman Demiroglu; E. Joanna Steer; Carol Heath; Kerry Taylor; Mark Bentley; Steven L. Allen; Prasad Koduru; Judith Brody; Geoffrey Hawson; Robyn Rodwell; Mary Lou. Doody; Fernando Carnicero; Andreas Reiter; John M. Goldman; Junia V. Melo; Nicholas C.P. Cross

Archive | 2017

need for further investigation into the effects of discontinuing imatinib therapy in those patients who wish to conceive.

Aya Kuwabara; Anna Babb; Amr R. Ibrahim; Dragana Milojkovic; Jane F. Apperley; Marco Bua; Katayoun Rezvani; John M. Goldman; David Marin

Archive | 2014

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients

Bua Marco; Christos Paliompeis; Alistair G. Reid; John M. Goldman; David Marin; Dragana Milojkovic

Archive | 2013

chronic myeloid leukemia immunotherapy in patients undergoing reduced intensity allografts for Post-transplant imatinib as a strategy to postpone the requirement for

Charles Craddock; Anne L. Lennard; Lalit Pallan; Julie Arrazi; Jolanta B. Perz; Derville O'Shea; John M. Goldman; Michael J. Griffiths; Sharon Avery; Jenny L. Byrne; Karen Piper

Archive | 2013

Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop. - eScholarship

Richard A. Van Etten; Michael J. Mauro; Jerald P. Radich; John M. Goldman; Giuseppe Saglio; Catriona Jamieson; Simona Soverini; Carlo Gambacorti-Passerini; R. Hehlmann; Giovanni Martinelli; Danilo Perrotti; David T. Scadden; Tomasz Skorski; Ayalew Tefferi; Tariq I Mughal

Archive | 2013

newly diagnosed patients with chronic myeloid leukemia in KIR2DS1 Dasatinib may overcome the negative prognostic impact of

Katayoun Rezvani; Nichola Cooper; John M. Goldman; Jane F. Apperley; Richard E. Clark; David Marin; Dragana Milojkovic; Kate Stringaris; Ahmad Khoder; Abdullah Alsuliman; Maria Gilleece; Stephen G. O'Brien; Letizia Foroni; Corinne Hedgley; Gareth Gerrard

Archive | 2013

lymphocytes specific for WT1 Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T

Hans J. Stauss; Liquan Gao; Ilaria Bellantuono; Annika Elsässer; Stephen B. Marley; Myrtle Y. Gordon; John M. Goldman

Archive | 2013

intention-to-treat analysis in chronic myeloid leukemia patients Responses to second-line tyrosine kinase inhibitors are durable: an

Alistair Reid; Katayoun Rezvani; Letizia Foroni; John M. Goldman; David Marin; Dragana Milojkovic; Jane F. Apperley; Gareth Gerrard; Amr R. Ibrahim; Richard Szydlo; Marco Bua

Archive | 2013

leukemia cells Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid

Alex J. Tipping; Francois Xavier Mahon; Valérie Lagarde; John M. Goldman; Junia V. Melo

Archive | 2013

study : Presented in part at the 43rd Annual Meeting of The American chronic myelogenous leukemia in myeloid blast crisis: results of a phase II Imatinib induces hematologic and cytogenetic responses in patients with

Ronald Paquette; Brian J. Druker; Christian Peschel; Gratwohl A; Franco Mandelli; Monique Ben-Am; Insa Gathmann; C. Shea; Chapuis B; Steven Coutre; Sante Tura; Enrica Morra; Richard A. Larson; S. G. O'Brien; Richard M. Stone; Carlo B. Gambacorti-Passerini; Nigel H. Russell; Jose Reiffers; Charles A. Schiffer; Moshe Talpaz; Francois Guilhot; Michael W. N. Deininger; L. Sawyers; Andreas Hochhaus; Eric J. Feldman; John M. Goldman; Carole B. Miller

Explore More